XmAb5871
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
IgG4-RD
Conditions
IgG4-RD
Trial Timeline
Mar 1, 2016 → Dec 1, 2017
NCT ID
NCT02725476About XmAb5871
XmAb5871 is a phase 2 stage product being developed by Xencor for IgG4-RD. The current trial status is completed. This product is registered under clinical trial identifier NCT02725476. Target conditions include IgG4-RD.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02867098 | Phase 1 | Completed |
| NCT02725476 | Phase 2 | Completed |